CCO Infectious Disease Podcast

COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators

Episode Summary

In which patients with COVID-19 should we use anti-inflammatory agents and immunomodulators? Hear expert insights on the timing and role of convalescent plasma, corticosteroids, IL-6 inhibitors, and JAK inhibitors in the treatment of COVID-19.

Episode Notes

Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.

In this episode, Vikramjit Mukherjee, MD, discusses the role and timing of these treatment options, including:

• High-titer convalescent plasma
• Corticosteroids
• Interleukin-6 inhibitors (eg, tocilizumab)
• Janus kinase inhibitors (eg, baricitinib)

Presenter:
Vikramjit Mukherjee, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York 

Review the downloadable slidesets at: 
https://bit.ly/35NNb7Q

Link to full program: 
https://bit.ly/35SrxQ0